Clinical Trial Update: Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia [NA]

View source ↗

Summary

Clinical trial evaluating ranolazine for microvascular coronary dysfunction (MCD) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Coronary Dysfunction

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Microvascular Coronary Dysfunction (MCD) | NA | Status: COMPLETED | Results posted: 2017-12-12